FDA Raises Alert on Nationwide Butter Recall
Undeclared milk in a popular butter blend prompts a nationwide recall and a heightened FDA warning.

A recent recall involving thousands of pounds of butter has been escalated by the U.S. Food and Drug Administration (FDA) due to serious allergen concerns.
What Triggered the Recall?
On July 14, Bunge North America Inc. voluntarily recalled 64,800 pounds—or about 1,800 cases—of its European Style Butter Blend 1 lb. product. The issue? The product contained milk, a major food allergen, which was not disclosed on the label. This oversight poses a health risk to people with milk allergies, prompting immediate action by regulators.
Heightened FDA Risk Classification
Initially classified as a routine recall, the FDA upgraded the situation on July 30 to a Class II recall. This is the second-highest level of concern and indicates that using the product could lead to temporary or medically reversible health problems. While the risk of serious long-term effects is considered low, the potential for allergic reactions remains significant.
Distribution and Identification
The affected butter was shipped in white paperboard cases, each containing 36 blocks, and distributed to 12 centers across the U.S. and one in the Dominican Republic. The lot code for the product is 5064036503, which consumers can use to identify if their purchase is part of the recall.
Understanding the Allergen Risk
Milk is one of nine major allergens that food producers are required to clearly list on packaging. Reactions to undeclared milk can range from mild symptoms such as hives or vomiting to severe outcomes like anaphylaxis, a potentially life-threatening condition. The FDA emphasized the importance of labeling regulations to prevent such risks and ensure consumer safety.
What Should Consumers Do?
Anyone who has purchased the affected butter should stop using it immediately. If symptoms of an allergic reaction occur—such as facial swelling, coughing, or nausea—individuals should consider emergency treatment, including epinephrine, and seek medical care.
The FDA has not reported any confirmed illnesses linked to this recall as of yet. However, consumers are encouraged to stay vigilant and check product labels carefully.
Reference(s)
- U.S. Food and Drug Administration. “Recalls Background and Definitions.” U.S. Food and Drug Administration <https://www.fda.gov/safety/industry-guidance-recalls/recalls-background-and-definitions>.
- U.S. Food and Drug Administration. “Food Allergies.” U.S. Food and Drug Administration <https://www.fda.gov/food/nutrition-food-labeling-and-critical-foods/food-allergies>.
- Mayo Clinic. “Anaphylaxis - Symptoms & Causes.” Mayo Clinic <https://www.mayoclinic.org/diseases-conditions/anaphylaxis/symptoms-causes/syc-20351468>.
Cite this page:
- Posted by Nida Hayat Khan